Mr. Charlie Bachtell reports

CRESCO LABS CLOSES US$50 MILLION REVOLVING CREDIT FACILITY WITH NEEDHAM BANK

Cresco Labs Inc. has closed a credit agreement with Needham Bank, a Massachusetts-based commercial bank, providing the company with a $50-million (U.S.) revolving credit facility.

For Cresco Labs and the broader cannabis sector, capital has historically come from private credit at elevated rates. The facility reflects the continued maturation of the industry, expanding access to more efficient sources of capital and further normalizing capital access for leading operators.

Borrowings under the facility will be available to finance growth initiatives, acquisitions and general corporate purposes. As a source of non-dilutive capital, the facility enhances Cresco's ability to pursue strategic opportunities that strengthen the company's balance sheet and long-term financial profile. The facility bears interest at a fixed annual rate of 7.99 per cent and matures in August, 2030.

"This facility reflects both the continued maturation of the industry and Cresco's position within it," said Charlie Bachtell, chief executive officer of Cresco Labs. "Access to conventional bank capital gives us a powerful, non-dilutive tool to accelerate our strategy. As demonstrated by our recent Pennsylvania acquisition, we see significant opportunities to deploy capital into assets that enhance earnings, improve margins and create long-term shareholder value. This added flexibility positions us to drive growth, strengthen our balance sheet and support Cresco as we work toward broader access to U.S. capital markets and a future uplisting to a senior exchange."

Needham Bank's Michelle Haughton, first vice-president, structured finance, said: "In addition to providing financing to fuel Cresco Labs' growth, Needham Bank is also providing a comprehensive suite of financial services including credit, state-of-the-art cash management and consumer payments to Cresco Labs, one of the largest publicly traded, multistate cannabis companies in the U.S. Our ability to provide a compliant, nationwide banking platform perfectly aligns with their strong operational and financial profile. We look forward to building a rewarding relationship with Cresco Labs for many years to come."

About Cresco Labs Inc.

Cresco Labs' mission is to normalize and professionalize the medical marijuana industry through a CPG (consumer packaged goods) approach to building national brands and a customer-focused retail experience while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the company is leveraging its scale and agility to grow its portfolio of brands (including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi) on a national level. The company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering continuing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED (social equity and educational development) initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, work force development and legislative initiatives designed to create the most responsible, respectable and robust medical marijuana industry possible.

We seek Safe Harbor.